CNS Pharmaceuticals, Inc. (CNSP)
| Market Cap | n/a-45.7% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,690 |
| Open | n/a |
| Previous Close | 5.30 |
| Day's Range | 5.08 - 5.43 |
| 52-Week Range | 1.90 - 10.56 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CNSP stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CNSP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CNSP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CNSP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CNSP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CNSP from public contracts
Source: USAspending.gov
CNSP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CNSP’s recent data — informational, not investment advice